MedPath

Rule-Based Closed Loop System for Type 1 Diabetes Control

Not Applicable
Completed
Conditions
Type 1 Diabetes
Registration Number
NCT01614496
Lead Sponsor
Corporacion Parc Tauli
Brief Summary

The aim of the study is to assess the efficacy and safety of a Rule-based Closed Loop system, using subcutaneous way, for the overnight and prandial glucose control in type 1 diabetic subjects. Ten subjects will be enrolled and they will participate in a cross-over study with a control night, using their usual insulin pump pattern, and with a experimental night, being controlled for the closed loop system. Each night includes the overnight control and prandial control of the breakfast.

The system proposes an insulin dose every 5 minutes according with the value of glucose displayed by the continuous glucose monitoring system.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Type 1 Diabetes
  • Insulin pump treatment
  • Undetectable C-Peptide
Exclusion Criteria
  • Autonomous system neuropathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time spent with glucose in the target range
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Endocrinology and Nutrition Department. Corporació Sanitària i Universitària Parc Taulí

🇪🇸

Sabadell, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath